Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Evidence that opioids may have toll-like receptor 4 and MD-2 effectsHutchinson, M.; Zhang, Y.; Shridhar, M.; Evans, J.; Buchanan, M.; Zhao, T.; Slivka, P.; Coats, B.; Rezvani, N.; Wieseler-Frank, J.; Hughes, T.; Landgraf, K.; Chan, S.; Fong, S.; Phipps, S.; Falke, J.; Maier, S.; Leinwand, L.; Yin, H.; Rice, K.; et al.
2010Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: A mechanism for improved insulin sensitivity in Type 2 diabetic CML patients?Fitter, S.; Vandyke, K.; Schultz, C.; White, D.; Hughes, T.; Zannettino, A.
2010Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cellsEadie, L.; Hughes, T.; White, D.
2010Nilotinib versus Imatinib for newly diagnosed chronic myeloid leukemiaSaglio, G.; Kim, D.; Issaragrisil, S.; le Coutre, P.; Etienne, G.; Lobo, C.; Pasquini, R.; Clark, R.; Hochhaus, A.; Hughes, T.; Gallagher, N.; Hoenekopp, A.; Haque, A.; Dong, M.; Larson, R.; Kantarjian, H.
2010Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with ImatinibWhite, D.; Dang, P.; Engler, J.; Frede, A.; Osborn, M.; Saunders, V.; Manley, P.; Zrim, S.; Hughes, T.
2010Primary tooth emergence in Australian children: timing, sequence and patterns of asymmetryWoodroffe, S.; Mihailidis, S.; Hughes, T.; Bockmann, M.; Seow, W.; Gotjamanos, T.; Townsend, G.
2010Genetic modeling of primary tooth emergence: A study of Australian twinsBockmann, M.; Hughes, T.; Townsend, G.
2010Detection of low level nilotinib or dasatinib resistant BCR-ABL mutations by mass spectrometry in CML patients who fail Imatinib is highly predivtive of their subsequent clonal expansion when treated with the drug for which their mutation confers resistanceParker, W.; Ho, M.; Lawrence, R.; Irwin, D.; Scott, H.; Hughes, T.; Branford, S.; American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)
2010Limiting the variability within a BCR-ABL quantitative PCR (RQ-PCR) assay is essential for optimal concordance of results between laboratories generating BCR-ABL values on an international reporting scaleFletcher, L.; Prime, J.; Phillis, S.; Jamison, B.; Field, C.; Prime, H.; Sullivan, B.; Yeoman, A.; Georgievski, J.; Parker, W.; Slader, C.; Hughes, T.; Branford, S.; Haematology Association of Australasia Annual Meeting (2010 : Auckland, New Zealand)
2010Contrasting response of patients with chronic myeloid leukaemia (CML) and the highly imatinib resistant L248V mutation that may be related to an increased propensity of some patients to form an associated deletion mutant with increased imatinib sensitivityPrime, H.; Romeo, G.; Phillis, S.; Field, C.; Jamison, B.; Prime, J.; Parker, W.; Joske, D.; Hughes, T.; Branford, S.; Haematology Association of Australasia Annual Meeting (2010 : Auckland, New Zealand)